We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Zynex Inc (ZYXI) USD0.001

Sell:$11.83 Buy:$11.85 Change: $0.68 (5.43%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $0.68 (5.43%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $0.68 (5.43%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zynex, Inc. designs, manufactures and markets medical devices, which treats chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation. The Company’s medical devices are small, portable, battery operated and include an electrical pulse generator, which is connected to the body via electrodes. Its primary product is the NexWave device. The NexWave is marketed to physicians and therapists by its field sales representatives. The NexWave requires consumable supplies, such as electrodes and batteries, which are shipped to patients on a recurring monthly basis, as needed.

Contact details

United States
+1 (303) 8673904

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$446.22 million
Shares in issue:
34.78 million
Health Care Equipment
United States
US dollar

Key personnel

  • Thomas Sandgaard
    Chairman of the Board, President, Chief Executive Officer
  • Daniel Moorhead
    Chief Financial Officer
  • Anna Lucsok
    Chief Operating Officer
  • Donald Gregg
    Vice President of Sales

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.